dextrose monohydrate + sodium chloride + potassium acetate

Dextrose monohydrate + sodium chloride + potassium acetate is a **multi-electrolyte intravenous fluid combination** intended for parenteral maintenance of routine daily fluid and electrolyte requirements while providing a small amount of carbohydrate calories from dextrose. Pharmacologically, this is not a receptor-targeted therapy; its therapeutic effect comes from supplying **water, glucose, sodium, chloride, potassium, and acetate ions** to help maintain intravascular and extracellular fluid balance, support electrolyte homeostasis, and provide limited caloric support. Based on the provided context, the exact three-component name appears to refer to a **nonproprietary component-level description** rather than a uniquely marketed drug product, and the closest identified commercial analogue is a broader electrolyte formulation such as Normosol-M and 5% Dextrose Injection, which also contains magnesium acetate. Accordingly, this entry is best treated as a specific electrolyte combination concept rather than a clearly validated standalone branded product.

Other names

dextrose monohydrate + sodium chloride + potassium acetate